Israel - Hospital Average Length of Stay for Malignant Neoplasm of Prostate
Since 2014, Israel Hospital Average Length of Stay for Malignant Neoplasm of Prostate fell by 6.2% year on year. At 4.8 Days in 2019, the country was number 24 among other countries in Hospital Average Length of Stay for Malignant Neoplasm of Prostate. South Korea lead the ranking with 15.9 Days in 2019, stable compared to 2018. New Zealand, Lithuania and Slovakia respectively ranked number 2, 3 and 4 in this ranking. New Zealand recorded the best 5 years average growth at +2.2% per year, while Mexico witnessed the worst performance at -8.8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 4.80 |
| 2018 | 4.90 |
| 2017 | 5.10 |
| 2016 | 5.00 |
| 2015 | 5.30 |
Download all data from 2000 to 2019
How does Israel rank in Hospital Average Length of Stay for Malignant Neoplasm of Prostate?
| # | 32 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
15.90 | 2019 | +0.0 % | -0.9 % | View data | |
| 2 |
#2
New Zealand
|
11.60 | 2019 | -0.8 % | +2.2 % | View data | |
| 23 |
#23
Turkey
|
5.30 | 2019 | +0.0 % | -1.8 % | View data | |
| 24 |
#24
Israel
|
4.80 | 2019 | -2.0 % | -6.2 % | View data | |
| 24 |
#24
United Kingdom
|
4.80 | 2019 | -4.0 % | -5.0 % | View data | |